Clare Bryant uses Co-Scientist to identify genetic triggers in emerging infectious diseases.
Machine-generated by The Flow from the publisher's headline and feed description — not written or checked by a human. The full article lives at DeepMind Blog.
Geneticist Catherine Brownstein demonstrates how OpenAI o1 can speed up the process of diagnosing rare medical challenges.
César de la Fuente’s laboratory employs Codex and ChatGPT to explore both living and extinct genomes in search of novel antimicrobial molecules. By leveraging these AI tools, the team aims to identify candidates that could help combat drug‑resistant infections.
Researchers used an OpenAI reasoning model to help diagnose rare diseases, identifying 18 new diagnoses in previously unsolved cases.
Introducing a new, unifying DNA sequence model that advances regulatory variant-effect prediction and promises to shed new light on genome function — now available via API.
arXiv:2609.13437v1 Announce Type: new Abstract: Scientific research is a continuous process that emphasizes inheritance. Methods developed by predecessors are often expanded upon by new researchers t...
OpenAI introduces GPT-Rosalind, a frontier reasoning model built to accelerate drug discovery, genomics analysis, protein reasoning, and scientific research workflows.
